Skip to main content

Christian Wojczewski

Equibles does not estimate personal net worth.

Get an email with a short summary when Evotec SE publishes a filing, an earnings call transcript or a press release.

Get EVO alerts

About Christian Wojczewski

Christian Wojczewski is recorded as CEO at Evotec SE (EVO). Christian Wojczewski has spoken on 9 earnings calls and 2 other investor events across 1 company, most recently for Evotec SE on November 5, 2026. Evotec SE is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

Christian Wojczewski on recent calls

“The third quarter of 2026 showed encouraging progress after a challenging first half. We're beginning to see the different pieces of our transformation come together and translate into improved business performance.”
CEO, Interim Statement Q3/9M 2026, Publications & Webcast ·
“I would say this improvement is mostly driven by the ongoing commercial transformation, which is also part of Horizon. Over the last couple of quarters, we have strengthened the organization and added new leadership to probably seen under a new chief commercial officer.”
CEO, RBC Pharma Services & Life Science Tools Conference / Webcast Evotec ·
“First of all, thanks, Joss, for having us here, and welcome, everyone. With regard to this space business, our market and our business has structurally evolved over the last years, including changes in customer behavior, funding dynamics, and also our own portfolio.”
CEO, 2026 RBC Pharma Services and Life Science Tools Virtual Conference ·
“Following our announcement last night, we are providing today an update based on preliminary unaudited financial results for the second quarter and first half of 2026, as well as an updated outlook for the full year.”
CEO, Earnings conference call (announced in 6-K) ·
“In the first quarter of 2026, we advanced Evotech's value creation levers, most notably with the initiation of the Horizon Business Transformation, which calibrates the company across the three pillars of operational excellence, science leadership, and commercial execution.”
CEO, Evotec SE Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Recent activity